Selvam Antonious, Durai Seran, Y Dishan, M Rajalakshmi, Radhakrishnan Praveen
Pulmonary Medicine, Pondicherry Institute of Medical Sciences, Puducherry, IND.
Pulmonary Medicine, Sri Venkateshwara Medical College and Hospital, Puducherry, IND.
Cureus. 2024 Nov 27;16(11):e74619. doi: 10.7759/cureus.74619. eCollection 2024 Nov.
Background Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition characterised by airflow limitation and reduced exercise capacity. The Six-Minute Walk Test (6MWT) and Two-Minute Walk Test (2MWT) are commonly used to assess functional exercise capacity in COPD patients. This study aims to evaluate the correlation between the distance covered in the 2MWT and 6MWT with spirometric indices (such as Forced Expiratory Volume in 1 second (FEV₁), Forced Vital Capacity (FVC), and FEV₁/FVC) in COPD patients. Materials and methods This cross-sectional study involved 50 severe and very severe COPD patients diagnosed according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria. Systematic random sampling was adopted to select the study participants. Each patient underwent spirometry to measure FEV₁, FVC, and FEV₁/FVC ratio. Following spirometry, both the 2MWT and 6MWT were conducted on separate days under standardised conditions. Results The average distance covered by the patients with very severe obstruction in 6MWT and 2MWT was 148±5.0 and 113.60±4.4. Patients with severe obstruction in 6MWT and 2MWT covered an average distance of 163.10±12.4 and 125.73±11.8, respectively. The mean FEV₁/FVC ratio and the mean FEV₁ % in 6MWT were 38.4 and 30.6 with a significant p-value of <0.001. The mean FEV₁/FVC ratio and the mean FEV₁ % in 2MWT were 32 and 29, respectively, with a significant p-value of <0.003. Both 2MWT and 6MWT distances were significantly correlated with spirometric indices, particularly FEV₁ and FEV₁/FVC ratio. Conclusion We found that there was no significant difference among spirometric indices between the two groups. Hence, 2MWT can be used as a reliable prognostic screening tool as it poses an advantage like decreasing the exhaustion for COPD patients as they find it more difficult to complete the 6MWT, resulting in increased heart rate and easy fatiguability.
背景 慢性阻塞性肺疾病(COPD)是一种进行性呼吸系统疾病,其特征为气流受限和运动能力下降。六分钟步行试验(6MWT)和两分钟步行试验(2MWT)常用于评估COPD患者的功能性运动能力。本研究旨在评估COPD患者2MWT和6MWT所走距离与肺量计指标(如一秒用力呼气量(FEV₁)、用力肺活量(FVC)和FEV₁/FVC)之间的相关性。
材料与方法 这项横断面研究纳入了50例根据慢性阻塞性肺疾病全球倡议(GOLD)标准诊断的重度和极重度COPD患者。采用系统随机抽样法选取研究参与者。每位患者均接受肺量计检查以测量FEV₁、FVC和FEV₁/FVC比值。肺量计检查后,在标准化条件下于不同日期进行2MWT和6MWT。
结果 极重度阻塞患者在6MWT和2MWT中所走的平均距离分别为148±5.0和113.60±4.4。重度阻塞患者在6MWT和2MWT中所走的平均距离分别为163.10±12.4和125.73±11.8。6MWT中的平均FEV₁/FVC比值和平均FEV₁%分别为38.4和30.6,p值显著<0.001。2MWT中的平均FEV₁/FVC比值和平均FEV₁%分别为32和29,p值显著<0.003。2MWT和6MWT的距离均与肺量计指标显著相关,尤其是FEV₁和FEV₁/FVC比值。
结论 我们发现两组之间的肺量计指标无显著差异。因此,2MWT可作为一种可靠的预后筛查工具,因为它具有优势,比如对于COPD患者而言,由于他们更难完成6MWT,完成2MWT会减少疲惫感,导致心率增加和易疲劳。